Development of gene therapy: potential in severe combined immunodeficiency due to adenosine deaminase deficiency

The history of stem cell gene therapy is strongly linked to the development of gene therapy for severe combined immunodeficiencies (SCID) and especially adenosine deaminase (ADA)-deficient SCID. Here we discuss the developments achieved in over two decades of clinical and laboratory research that le...

Descripción completa

Detalles Bibliográficos
Autores principales: Montiel-Equihua, Claudia A, Thrasher, Adrian J, Gaspar, H Bobby
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781725/
https://www.ncbi.nlm.nih.gov/pubmed/24198507

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3781725/
https://www.ncbi.nlm.nih.gov/pubmed/24198507

Ejemplares similares